The current study suggests that an impairment in insulin-stimulated myocardial glucose metabolic rate assessed by 18F-FGD PET scan combined with euglycemic hyperinsulinemic clamp is associated with a decrease in myocardial mechano-energetic efficiency, and an increased cardiac workload in subjects with different glucose tolerance status without history of CHD. This evidence concerns the gene INS and coronary artery disorder.